Existing studies have reported the regulatory mechanism of Bcl-2 and CCND1 in cancer cells, including the post-transcriptional downregulation by miR-15 and miR-16 (Cimmino et al., 2005; Pekarsky and Croce, 2015; Pekarsky et al., 2018). Here, BCL2 is linked to cancer.